Physician profile
William O Suddath
NPI 1104876333
$5,101.72
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,056 · 2020: $472 · 2021: $381 · 2022: $567 · 2023: $606 · 2024: $20.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,519.63 | 2019-2023 | Lifevest |
| Medtronic, INC. | $575.37 | 2021-2023 | Onyx Frontier, Telescope |
| Astrazeneca Pharmaceuticals LP | $264.84 | 2019-2022 | |
| Pfizer INC. | $264.36 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $248.62 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.29 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $215.21 | 2021-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $187.31 | 2019-2021 | |
| Amgen INC. | $122.82 | 2020-2021 | |
| Chiesi USA, INC. | $84.53 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $73.05 | 2019-2021 | |
| Novo Nordisk INC | $66.20 | 2022-2023 | Rybelsus, Ozempic |
| Irhythm Technologies, INC. | $54.19 | 2019-2021 | |
| Esperion Therapeutics, INC. | $50.90 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $50.74 | 2019-2023 | Eliquis |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $31.93 | 2019 | |
| Alnylam Pharmaceuticals INC. | $26.57 | 2022 | |
| Celonova Biosciences, INC. | $20.67 | 2020 | |
| Biotronik INC. | $14.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Suddath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.